Free Trial

Neonc Technologies (NTHI) Competitors

Neonc Technologies logo
$4.79 -0.01 (-0.21%)
As of 08/8/2025 04:00 PM Eastern

NTHI vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Neonc Technologies stock or one of its competitors? The main competitors of Neonc Technologies include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Neonc Technologies vs. Its Competitors

Neonc Technologies (NASDAQ:NTHI) and 180 Life Sciences (NASDAQ:ATNFW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

In the previous week, Neonc Technologies had 3 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Neonc Technologies and 0 mentions for 180 Life Sciences. Neonc Technologies' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Neonc Technologies Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Neonc TechnologiesN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neonc Technologies$79.99KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Neonc Technologies beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Neonc Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTHI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NTHI vs. The Competition

MetricNeonc TechnologiesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$857.25M$2.54B$9.72B
Dividend YieldN/A4.84%2.57%4.12%
P/E RatioN/A1.1422.2124.75
Price / SalesN/A26.6685.2297.82
Price / CashN/A19.5623.8958.47
Price / BookN/A6.5437.735.59
Net IncomeN/A-$4.07M$31.01M$265.99M
7 Day Performance0.84%121.77%1.55%5.06%
1 Month Performance-1.84%1.87%1.15%0.61%
1 Year PerformanceN/A22.82%28.08%22.82%

Neonc Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NTHI
Neonc Technologies
N/A$4.79
-0.2%
N/AN/A$0.00$79.99K0.008Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+1.0%
N/A+15.1%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.35
+220.2%
N/AN/A$0.00$106.21K0.0040Gap Down
High Trading Volume
ALVOW
Alvotech
N/A$1.31
-18.1%
N/A-49.6%$0.00$585.60M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
+2.9%
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.14
-9.9%
N/AN/A$0.00$38.00M0.0070Gap Up
BTMDW
biote
N/A$0.02
+19.3%
N/A-97.5%$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.03
-27.9%
N/A-83.7%$0.00N/A0.008Gap Down
High Trading Volume
CELUW
Celularity
N/A$0.05
flat
N/AN/A$0.00$54.22M0.00220Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:NTHI) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners